Shawn Iadonato
Fundador en KINETA, INC. .
Fortuna: 437 621 $ al 30/04/2024
Relaciones activas
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Robert Hedequist | M | - |
Kineta Immuno-Oncology LLC
 Kineta Immuno-Oncology LLC BiotechnologyHealth Technology Kineta Immuno-Oncology LLC operates as a biotech company. It specializes in RIG-I pathway, tumor immunity, publications and posters. The company was founded in 2016 and is headquartered in Seattle, WA.
Kineta, Inc. (Washington)
 Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA.
Kineta Chronic Pain LLC
 Kineta Chronic Pain LLC Miscellaneous Commercial ServicesCommercial Services Kineta Chronic Pain LLC operates as a biotechnology company. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense systems. The company was founded in 2011 and is headquartered in Seattle, WA. | - |
| Craig Philips | M | 64 |
Kineta, Inc. (Washington)
Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA.
Kineta Viral Hemorrhagic Fever LLC
 Kineta Viral Hemorrhagic Fever LLC BiotechnologyHealth Technology Kineta Viral Hemorrhagic Fever LLC provides biotechnology health care services. The company is headquartered in Seattle, WA.
Kv1.3 Therapeutics, Inc.
 Kv1.3 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kv1.3 Therapeutics, Inc. operates as a clinical stage biopharmaceutical firm. It focuses on providing new treatment options for rare autoimmune diseases. The company was founded in 2009 and is headquartered in Seattle, WA. | 11 años |
| Raymond Bartoszek | M | 59 |
Kineta, Inc. (Washington)
Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | 7 años |
| Keith Baker | M | 57 |
Kineta, Inc. (Washington)
Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA.
Kineta Viral Hemorrhagic Fever LLC
Kineta Viral Hemorrhagic Fever LLC BiotechnologyHealth Technology Kineta Viral Hemorrhagic Fever LLC provides biotechnology health care services. The company is headquartered in Seattle, WA. | 2 años |
| Pauline Kenny | F | 51 |
Kineta Viral Hemorrhagic Fever LLC
Kineta Viral Hemorrhagic Fever LLC BiotechnologyHealth Technology Kineta Viral Hemorrhagic Fever LLC provides biotechnology health care services. The company is headquartered in Seattle, WA. | 12 años |
| Marion Foote | F | 78 |
Kineta, Inc. (Washington)
Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | 7 años |
| David Arkowitz | M | 62 | 2 años | |
| Kyung-Won Oh | M | 53 | - | |
| Kimberlee Drapkin | F | 56 | 1 años | |
| Richard Peters | M | 61 | 2 años | |
| Scott Dylla | M | 49 | 1 años | |
| Bong-Doo Seong | M | 65 | - | |
| Young-Ju Byun | M | 51 | - | |
| Molly Dorr | F | - |
Kineta, Inc. (Washington)
Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | 9 años |
| Yook Jang | M | 48 | - | |
| Jae-Hyung Jo | M | 45 | - | |
| Seong-Hee Lee | M | 54 | - | |
| Tae-Hoon Kim | M | 42 | - | |
| Hyeok-Gon Kwon | M | 39 | - | |
| Ernesto Muñoz | M | - |
Kineta, Inc. (Washington)
Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | - |
| Dong-Yup Lee | M | 44 | - | |
| Hui-Joon Kang | M | 52 | - | |
| Ho-Jun Lee | M | 50 | - | |
| Gavin Jancke | M | - |
Kv1.3 Therapeutics, Inc.
Kv1.3 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kv1.3 Therapeutics, Inc. operates as a clinical stage biopharmaceutical firm. It focuses on providing new treatment options for rare autoimmune diseases. The company was founded in 2009 and is headquartered in Seattle, WA. | - |
| Daniel Raymond | M | - |
Kv1.3 Therapeutics, Inc.
Kv1.3 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kv1.3 Therapeutics, Inc. operates as a clinical stage biopharmaceutical firm. It focuses on providing new treatment options for rare autoimmune diseases. The company was founded in 2009 and is headquartered in Seattle, WA. | - |
| Lucien Fouke | M | - |
Kv1.3 Therapeutics, Inc.
Kv1.3 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kv1.3 Therapeutics, Inc. operates as a clinical stage biopharmaceutical firm. It focuses on providing new treatment options for rare autoimmune diseases. The company was founded in 2009 and is headquartered in Seattle, WA. | - |
| Richard Samuelson | M | - |
Kineta, Inc. (Washington)
Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | - |
| Don Merlino | M | - |
Kineta, Inc. (Washington)
Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | - |
| Ji-Young Hwang | F | 47 | - | |
| Steve Mitchell | M | 54 |
Kineta, Inc. (Washington)
Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | - |
| Michael O. Banks | M | 64 |
Kv1.3 Therapeutics, Inc.
Kv1.3 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kv1.3 Therapeutics, Inc. operates as a clinical stage biopharmaceutical firm. It focuses on providing new treatment options for rare autoimmune diseases. The company was founded in 2009 and is headquartered in Seattle, WA. | - |
| Thierry Guillaudeux | M | 57 | 4 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Charles Magness | M | - |
Illumigen Biosciences, Inc.
 Illumigen Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Illumigen Biosciences, Inc. provides pharmaceutical research services. It develops human genetic mutations that provide roadmap for therapeutic drug mechanisms. The company's product IB657 helps to investigate the cause of apparent immunity to HCV infection. Illumigen Biosciences was founded by Dr. Charles Magness and Shawn Iadonato in 2000 and is located in Seattle, WA | 7 años |
| Kenneth North | M | - |
Kineta, Inc. (Washington)
Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | - |
| Kristin Bedard | M | - |
Kineta, Inc. (Washington)
Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | 4 años |
| Jiyoung Hwang | M | - |
Kineta, Inc. (Washington)
Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | - |
| Jacques Bouchy | M | - | 10 años |
Estadísticas
| País | Relaciones | % del total |
|---|---|---|
| Estados Unidos | 25 | 67.57% |
| Corea del Sur | 13 | 35.14% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Shawn Iadonato
- Red Personal
